Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$20.19 -0.25 (-1.22%)
At close: Oct 21, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Short term Debt (2010 - 2012)

Updated

Acadia Pharmaceuticals (ACAD) recorded Short term Debt of $22,000 in Q1 2012, down 31.3% from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Short term Debt (2010 - 2012) Analysis & Trends

At the end of FY2011, Acadia Pharmaceuticals reported Short term Debt of $32,000, down 59.0% from FY2010.

  • Across earlier years, Short term Debt came in at $78,000 in FY2010.
  • Per Business Quant, the preceding three quarters came in at $32,000 (Q4 2011), $37,000 (Q3 2011) and $40,000 (Q2 2011).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Acadia Pharmaceuticals 3.47 Bn -4.91 Mn 279.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2012 22,000.00
Dec 31, 2011 32,000.00
Sep 30, 2011 37,000.00
Jun 30, 2011 40,000.00
Dec 31, 2010 78,000.00
API Access

Acadia Pharmaceuticals Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=ACAD&period=max&api_key=YOUR_API_KEY